Umbilical Cord Mesenchymal Stem Cell Therapy · Tijuana, Mexico

The future of advanced healing and recovery is now.

Stem cells, particularly umbilical cord–derived mesenchymal stem cells (UC-MSCs), stand at the forefront of modern medical research — offering groundbreaking, ethically-sourced solutions for a wide range of degenerative and chronic conditions.

94,300+
Peer-reviewed MSC studies indexed on PubMed
1,600+
Active clinical trials worldwide using MSCs
39
Conditions studied for stem cell response
cGMP · ISO
COFEPRIS-registered laboratory standard

The Science

From a single umbilical cord, the body's own repair kit.

Regenerative medicine harnesses the body's inherent healing mechanisms — stem cell therapy and immune modulation — to repair damage that the body cannot resolve on its own. Here is the biology behind the treatment, in plain terms.

Researcher drawing a sample into a pipette above a glass culture dish

Adult stem cells,
not embryonic.

Human stem cells fall into two categories: embryonic and adult. Embryonic stem cells are controversial and carry a real risk of uncontrolled growth, as they are sourced from human embryos. None of the products used in treatment at Biostem contain embryonic stem cells or involve aborted fetal tissue.

Adult stem cells are instead harvested from tissue sources such as umbilical cord, bone marrow, and adipose tissue — from consenting donors, with no ethical conflict. Current research overwhelmingly favors adult stem cells for clinical use, given their targeted differentiation potential, accessibility, and negligible risk of tumor formation.

Mesenchymal stem cells (MSCs).

Mesenchymal stem cells are a class of adult stem cells with self-renewal, anti-inflammatory, signaling, and multi-lineage differentiation properties. Because they are not sourced from embryonic material, MSCs present no ethical concern — and a deep body of in-vitro and in-vivo research supports their mechanism, safety, and clinical efficacy across a wide range of degenerative conditions.

Why umbilical cord (UC-MSC)?

Not all MSCs are equal. Umbilical cord tissue — specifically Wharton's Jelly, the gelatinous matrix that cushions the cord's vessels — yields cells that are younger, more proliferative, and less immunologically reactive than MSCs sourced from bone marrow or adipose tissue.

Compared to bone-marrow-derived MSCs, Wharton's Jelly MSCs show increased division and telomerase activity, and no HLA Class I expression — meaning no risk of immune rejection. They can be directed toward osteoblasts, chondrocytes, adipocytes, myocytes, cardiomyocytes, glial cells, and dopaminergic neurons, and are collected non-invasively from ethically donated, full-term cesarean births — tissue once discarded as medical waste.

Cytokines & paracrine signaling.

MSCs do most of their work by secretion, not by becoming the tissue itself. They release cytokines — signaling proteins that suppress inflammation, recruit the body's own repair cells, and stimulate angiogenesis (new blood vessel formation) around damaged tissue. This paracrine effect is what allows a single administration to influence a much larger field of tissue than the injected cells alone could reach. Every cytokine profile is verified by an independent third-party laboratory before shipment.

Stem cells vs. exosomes

Stem cellsExosomes
Undifferentiated cellsNot cells — vesicles released by cells
Divide and differentiate~1/1000th the size of a cell; no DNA or mitochondria
Replace and rebuild tissue directlyCarry mRNA, proteins & microRNA between cells
Engraft at the treatment siteTravel to distant tissue, modulating behavior remotely

PRP vs. UC-MSC therapy

PRP therapyUC-MSC therapy
Concentrated platelets from the patient's own bloodLiving mesenchymal stem cells from donated cord tissue
Best for acute tendon, ligament & muscle injuriesBroader application in degenerative & systemic conditions
Works within days; 1–3 sessions typicalPeak results generally at 3–6 months
Enhances the body's own healing signalHigher regenerative & anti-inflammatory potential

Conditions Studied

Peer-reviewed applications across six systems.

This list reflects conditions studied in the peer-reviewed literature indexed by the National Library of Medicine — not a guarantee of outcome. Candidacy is always confirmed through medical screening.

Orthopedic & Musculoskeletal

05 conditions
  • Osteoarthritis
  • Degenerative joint disease
  • Rheumatoid arthritis
  • Cartilage defects
  • Bone fractures & non-union

Neurological

07 conditions
  • Spinal cord injuries
  • Traumatic brain injury
  • Chronic traumatic encephalopathy (CTE)
  • Multiple sclerosis
  • Alzheimer's disease
  • Parkinson's disease
  • Spinal muscular atrophy

Cardiovascular

06 conditions
  • Heart disease
  • Stroke
  • Ischemic heart disease
  • Dilated cardiomyopathy
  • Congestive heart failure
  • Peripheral arterial disease

Metabolic, Organ & Respiratory

09 conditions
  • Type 1 & type 2 diabetes
  • End-stage liver disease
  • Liver cirrhosis
  • Acute liver failure
  • Chronic & acute kidney injury
  • COPD
  • Idiopathic pulmonary fibrosis

Autoimmune & Inflammatory

06 conditions
  • Chronic inflammatory systemic disease
  • Systemic lupus erythematosus
  • Sjögren's syndrome
  • Crohn's disease
  • Ulcerative colitis
  • Cystic fibrosis

Regenerative & Other Applications

05 conditions
  • Burns
  • Skin diseases
  • Degenerative diseases
  • Ischemic diseases
  • Age-related macular degeneration

Applications in Practice

Where regeneration shows up first.

Orthopedic and sports-medicine applications carry the deepest evidence base — from cartilage regeneration to full alternative pathways around joint replacement surgery.

01 — Joints

Joint & cartilage repair

MSCs differentiate into chondrocytes to rebuild damaged cartilage in the knees, shoulders, hips, ankles, elbows, hands and feet — while their anti-inflammatory secretions protect the cartilage that remains and improve synovial fluid quality.

02 — Soft Tissue

Tendon & ligament injury

MSCs differentiate into tenocytes and ligament fibroblasts, strengthening collagen matrix and improving vascularization — accelerating recovery from tears and chronic overuse injury with a lower risk of re-injury.

03 — Performance

Athletic recovery

Athletes use stem cell therapy to shorten downtime, strengthen vulnerable tissue proactively, and reduce the chronic inflammation that accumulates from repeated high-impact training and competition.

Clinical Data — Knee Osteoarthritis

86% pain reduction at 12 months.

In controlled follow-up of intra-articular UC-MSC treatment for knee osteoarthritis, treated patients experienced an 86% reduction in pain and an 89% reduction in disability at 12 months — compared to 38% and 50% in the group treated with hyaluronic acid alone. Improvements remained stable over 7 years of follow-up, with no cases of severe adverse events, osteogenesis, or tumorigenesis.

An Alternative Path

A route around surgery — where appropriate.

Stem cell therapy cannot correct a structural or mechanical injury on its own. But for patients who are not surgical candidates, or who want to reduce dependence on corticosteroids, NSAIDs, or opioids for long-term pain management, it offers a less invasive option — and is often used post-operatively to accelerate healing as well.

Safety & Sourcing

Every product traced back to a single, screened donor.

Unmonitored clinics prioritize volume over viability. We exclusively partner with Latin America's leading stem cell production laboratory — over 14 years in stem cell research and development — and require independent third-party verification on every batch.

COFEPRIS Registered cGMP Compliant ISO 9001 Certified ISO 13485 Certified ISBT 128 & ICCBBA Aligned Independent Third-Party Testing
Technician preparing vials under a laminar flow hood in a cGMP cleanroom

Donor screening standard

Umbilical cords are sourced from private birthing centers in Guadalajara, Mexico — not hospitals — following a healthy, live, full-term cesarean birth. Every donor must clear:

  • 01 Age 18–24, first-time mother
  • 02 No history of miscarriage or abortion
  • 03 No history of drug or alcohol use
  • 04 No SARS-CoV-2 vaccination or booster, verified by CURP registry
  • 05 Full serological & infectious disease screening
  • 06 Comprehensive clinical history review

Immune privileged, by design

UC-MSCs express low levels of MHC Class I molecules and no MHC Class II — allowing them to evade recognition by T-lymphocytes. That means no HLA matching, no blood products, and no meaningful risk of immune rejection with allogeneic (donor) administration.

"MSC administration was safe in different populations compared with other placebo modalities."

Wang, Yi & Song — Stem Cell Research & Therapy, 2021 meta-analysis of 62 randomized clinical trials, 3,546 participants

Why Tijuana

A short drive from the U.S. border.

The FDA classifies cultured, expanded MSC therapy as a "drug" and has not approved it for the conditions in this list — leaving patients to seek regulated care abroad. Mexico, alongside Colombia and Panama, offers the same therapy 100% legally.

Regulatory Gap

Why it isn't offered in the U.S.

The only FDA-approved stem cell treatment in the United States is hematopoietic (blood) stem cell transplantation for blood and immune cancers. Mesenchymal stem cell therapy for orthopedic, neurological, autoimmune and other chronic conditions remains classified as investigational — despite a decades-long regulatory stalemate and a growing body of international evidence.

Access & Cost

World-class care, without the wait.

Tijuana has become a leading destination for medical tourism: modern facilities, physicians trained in the U.S. and Europe, appointment availability within days rather than months, and treatment costs a fraction of comparable care north of the border.

Concierge Support

Handled, door to door.

Our patient concierge coordinates transportation and hotel accommodations ahead of your visit. Many patients combine treatment with a short recovery stay near the coast — typical lead time from approval to treatment is 2 weeks to 1 month.

The Facility

See where treatment happens.

A walkthrough of our partner clinic in Tijuana — the same private, cGMP-aligned facility where your consultation, labs and treatment take place.

The Process

From screening to treatment day.

A complimentary initial review starts the process — a full medical consultation follows, either virtually or in person, before any treatment is scheduled.

01

Screening application

A short intake form determines whether you're a reasonable candidate to begin the pre-treatment process.

02

Prerequisites

You'll receive a list of labs and intake forms that must be completed before final treatment clearance is issued.

03

Final medical review

Our medical team reviews everything submitted and either clears you to proceed or requests additional information.

04

Schedule treatment

Once approved, book your treatment date subject to availability — typical lead time is 2 weeks to 1 month, with concierge support arranged around your visit.

Pre- & Post-Treatment Protocol

  • Smoking & alcohol — avoid for at least one week before and after treatment.
  • NSAIDs — discontinue one week prior; avoid for two weeks after — they interfere with the inflammatory signaling MSCs rely on.
  • Corticosteroid injections — none within three months prior to treatment.
  • Prednisone — stop one week before; avoid for two weeks following treatment.
  • Activity — rest for two weeks post-treatment, followed by a four-week guided physical rehabilitation protocol.
  • Timeline — most patients reach optimal results between three and six months post-treatment.

Candidacy & Contraindications

  • Patients with a cancer diagnosis within the past 5 years are not candidates for standard stem cell therapy — ask about our Natural Killer Cell and Dendritic Cell Therapy programs instead.
  • Ideal dosage is calculated individually — factoring overall health, administration site(s), body weight, and condition severity.
  • The type and severity of the condition being treated materially affects expected outcome; not every condition responds equally.
  • All deposits are fully refundable up to 14 days before your scheduled date; rescheduling carries no extra charge.
  • Treatment costs are not currently covered by insurance or Medicare, as therapy is classified as investigational in the U.S.

Frequently Asked

Every question we hear, organized.

Search or filter by topic — from the biology itself to what your trip to Tijuana actually looks like.

Stem Cells & ScienceWhat are mesenchymal stem cells (MSCs)?
MSCs are a class of adult stem cells with self-renewal, anti-inflammatory, signaling, and multi-lineage differentiation properties. Unlike embryonic stem cells, they carry no ethical conflict, and a large body of in-vitro and in-vivo research supports their safety and clinical mechanism across a wide range of degenerative conditions.
Stem Cells & ScienceAre these embryonic stem cells?
No. None of the products used in treatment at Biostem contain embryonic stem cells or involve aborted fetal tissue. All cells are adult mesenchymal stem cells harvested from umbilical cord tissue donated after a healthy, full-term birth — a source current research overwhelmingly favors for clinical use.
Stem Cells & ScienceWhy umbilical cord–derived cells specifically?
Umbilical cord tissue — specifically Wharton's Jelly — yields cells that are younger, more proliferative, and less immunologically reactive than MSCs sourced from bone marrow or adipose tissue, with no HLA Class I expression and therefore no risk of immune rejection.
Stem Cells & ScienceWhat's the difference between stem cells and exosomes?
Stem cells are living, undifferentiated cells that can divide, differentiate, and engraft at the treatment site. Exosomes are not cells at all — they're vesicles roughly 1/1000th the size of a cell, with no DNA or mitochondria, that carry mRNA, proteins and microRNA between cells and can travel to distant tissue.
Stem Cells & ScienceHow do stem cells actually reduce pain and inflammation?
Mostly through secretion, not by becoming the tissue itself. MSCs release cytokines — signaling proteins that suppress inflammation, recruit the body's own repair cells, and stimulate new blood vessel formation around damaged tissue. This "paracrine effect" lets a single administration influence a much larger field of tissue than the injected cells alone.
Stem Cells & ScienceWhere do your stem cells come from?
All UC-MSCs are sourced from ethically donated, full-term umbilical cords collected at private birthing centers in Guadalajara, Mexico, following rigorous donor screening. Cells are prepared in a COFEPRIS-registered, cGMP-compliant, ISO 9001 and ISO 13485 certified laboratory, and every batch is independently tested for purity, potency, viability, and cell count before shipment.
Candidacy & TreatmentWhat conditions do you treat?
Our screening covers 39 conditions studied in the peer-reviewed literature across six systems — orthopedic, neurological, cardiovascular, metabolic/organ/respiratory, autoimmune, and other regenerative applications. See the full list in the Conditions Studied section above; candidacy is always confirmed through individual medical screening, not by category alone.
Candidacy & TreatmentWhat determines whether treatment will be effective for me?
Three factors matter most: the type and severity of the condition being treated, the quality and source of the stem cells used, and the dosage — calculated individually based on your health, weight, and the site(s) of administration. Our medical team reviews all three during the screening and clearance process.
Candidacy & TreatmentCan stem cell therapy help me avoid surgery?
Potentially — though it depends on the severity and mechanical nature of the injury. Stem cells cannot repair a structural issue that requires surgical correction, but many patients use therapy to delay or avoid joint replacement, reduce reliance on steroid injections and painkillers, or accelerate healing after a procedure.
Candidacy & TreatmentHow long do the effects of stem cell therapy last?
Duration depends on the condition treated, your overall health, and the type of therapy administered. Many patients report meaningful relief and improved quality of life for several years; some conditions may benefit from additional treatments over time depending on individual response. Most patients reach their optimal result between three and six months post-treatment.
Candidacy & TreatmentHow is stem cell therapy different from PRP?
PRP (platelet-rich plasma) uses concentrated platelets from your own blood and works best for acute tendon, ligament and muscle injuries, with results in days over 1–3 sessions. UC-MSC therapy uses living donor stem cells, has broader application across degenerative and systemic conditions, and generally shows higher regenerative and anti-inflammatory potential, with peak results at 3–6 months.
Candidacy & TreatmentWho is not a candidate for treatment?
Patients with a cancer diagnosis within the past 5 years are not candidates for standard stem cell therapy — ask our team about the Natural Killer Cell and Dendritic Cell Therapy programs instead. Final candidacy is always confirmed by our medical team after reviewing your full intake, labs, and history.
Safety & SourcingIs stem cell therapy FDA approved?
No. The only stem cell–based treatment routinely approved by the FDA is hematopoietic (blood) stem cell transplantation for cancers and disorders of the blood and immune system. Cultured, expanded mesenchymal stem cell therapy for the conditions listed on this site is still considered investigational in the United States — which is why patients seek regulated treatment in countries like Mexico, where it is fully legal.
Safety & SourcingHow are your donors screened?
Umbilical cords are sourced from private birthing centers in Guadalajara, Mexico following a healthy, live, full-term cesarean birth. Every donor must be 18–24 and a first-time mother, with no history of miscarriage, abortion, drug or alcohol use, no SARS-CoV-2 vaccination or booster (verified by CURP registry), full serological and infectious disease screening, and a comprehensive clinical history review.
Safety & SourcingWhat certifications and standards do you follow?
Our laboratory partner is COFEPRIS-registered, cGMP-compliant, and ISO 9001 / ISO 13485 certified, aligned with ISBT 128 and ICCBBA standards. Every batch of cells is independently tested by a third-party laboratory for purity, potency, viability and cell count before it ships.
Safety & SourcingIs there a risk of immune rejection?
UC-MSCs express low levels of MHC Class I molecules and no MHC Class II, which lets them evade recognition by T-lymphocytes. That means no HLA matching and no blood products are required, and there is no meaningful risk of immune rejection with allogeneic (donor) administration — a finding supported by a 2021 meta-analysis of 62 randomized clinical trials covering 3,546 participants.
Cost & PoliciesIs treatment covered by insurance or Medicare?
No. Because the therapy is classified as investigational in the U.S., it is not currently covered by insurance or Medicare, regardless of where treatment is administered.
Cost & PoliciesHow is pricing determined?
Cost depends on the condition being treated, the dosage required, and the number of administration sites — there's no flat rate, since dosage is calculated individually. Request a consultation and our team will walk you through a personalized quote once your case has been reviewed.
Cost & PoliciesWhat is your cancellation policy?
All deposits are fully refundable up to two weeks (14 days) before your scheduled treatment date. If you need to reschedule, our patient management team will help you select a new date at no extra charge.
Visiting & LogisticsWhy is this treatment legal in Mexico but not the U.S.?
The only FDA-approved stem cell treatment in the U.S. is hematopoietic transplantation for blood and immune cancers. Mesenchymal stem cell therapy for orthopedic, neurological, autoimmune and other chronic conditions remains classified as investigational — despite a decades-long regulatory stalemate. Mexico, alongside Colombia and Panama, permits the same therapy 100% legally.
Visiting & LogisticsDo you help with travel and accommodations?
Yes. Our patient concierge coordinates transportation and hotel accommodations ahead of your visit. Many patients combine treatment with a short recovery stay near the coast; typical lead time from approval to treatment day is 2 weeks to 1 month.
Visiting & LogisticsWhat should I do to prepare before treatment?
Avoid smoking and alcohol for at least one week before and after treatment. Discontinue NSAIDs one week prior (and for two weeks after), avoid corticosteroid injections within three months of treatment, and stop prednisone one week before — these interfere with the inflammatory signaling MSCs rely on. Your care team will confirm your specific protocol during screening.
Visiting & LogisticsWhat does recovery look like after treatment?
Plan on two weeks of rest post-treatment, followed by a four-week guided physical rehabilitation protocol. Most patients reach their optimal result between three and six months post-treatment, though timelines vary by condition and individual response.
Visiting & LogisticsDo I need a visa to visit Tijuana for treatment?
Entry requirements depend on your nationality. Most patients traveling from the U.S. and Canada need only a valid passport for a short visit. We recommend confirming your specific entry requirements with Mexican consular authorities before booking, and our concierge team can help point you to the right resources.
Getting StartedHow do I begin the process?
Start with the patient evaluation form below — a short intake that determines whether you're a reasonable candidate to begin the pre-treatment process. From there you'll receive a list of any labs and forms needed before final medical clearance, followed by scheduling.
Getting StartedWhat is the patient evaluation form for?
It gives our medical team the information needed to evaluate your case — medical history, current medications, prior diagnostics, and the specific area(s) affecting you — so they can give you an honest read on candidacy before you travel anywhere.
Getting StartedCan I have prior imaging or records reviewed?
Yes — the patient evaluation form includes upload fields for MRIs, CT scans, X-rays, bloodwork, operative reports and other records, so our medical team can factor your existing diagnostics into the initial review rather than starting from scratch.

Get Started

Request your complimentary consultation.

Tell us about your condition and our medical team will follow up to schedule a virtual or in-person review — the first step of the screening process, at no cost.

No obligation Virtual or in-person Response within 1–2 business days

A longer form — scroll within it to move through all sections. This is a draft placeholder; connect it to your patient-intake system before publishing live.

The information on this site is intended for general knowledge and informational purposes only. It is not a substitute for professional medical advice from a qualified provider, nor a guarantee of treatment outcome.